Kelsian is a tourism stock that has slipped under investors’ radar but has made a solid ~60% return in 5 years

Nick Sundich Nick Sundich, February 23, 2023

If you think you knew all the tourism stocks that are listed on the ASX, think again. Kelsian (ASX:KLS) is a tourism stock that has slipped under the radar, but is benefiting from the rebound in travel – and not just tourism. 

 

No time to do stock research, but you still want to invest?

 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 
Kelsian is a unique tourism stock

Kelsian is a transport provider that not only provides tourism transport but commuter transport too.

It operates 3,991 buses, 113 vessels and 24 light rail vehicles that have delivered over 257m customer journeys over the last 12 months. 

The company’s commuter operations include bus services in London and Singapore and ferry services in Brisbane. It also operates several tourism brands including adventure tour and cruise brands. 

In the last five years, Kelsian’s share price has grown by over 60%, something that can’t be said for many travel and tourism stocks. 

 

Kelsian (ASX:KLS) share price chart, log scale (Source: TradingView)

 

Kelsian grows its profit by 22%

In 1HY23, Kelsian grew its underlying NPAT by 21.6% to $26.5m and it paid a dividend of 7.5c a share (whch is a 2.5% yield on an annualised basis). 

Kelsian’s revenues grew by 6.2% to $678.3m, a growth figure that trails many of its peers but is more stable given its reliance on government-backed service contracts.

The company also reported that trading in 2H continued to be strong, more than offsetting cost headwinds associated with ongoing labour shortages. 

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
 
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…